An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment
The COVID-19 pandemic is one of the greatest threats to human health in the 21st century
with more than 257 million cases and over 5.17 million deaths reported worldwide (as of …
with more than 257 million cases and over 5.17 million deaths reported worldwide (as of …
Association of obesity with COVID-19 severity and mortality: an updated systemic review, meta-analysis, and meta-regression
R Singh, SS Rathore, H Khan, S Karale… - Frontiers in …, 2022 - frontiersin.org
Background Obesity affects the course of critical illnesses. We aimed to estimate the
association of obesity with the severity and mortality in coronavirus disease 2019 (COVID …
association of obesity with the severity and mortality in coronavirus disease 2019 (COVID …
[HTML][HTML] Pandemics throughout the history
As we move amidst the coronavirus disease 2019 (COVID-19) pandemic, we have
witnessed tremendous distress, death, and turmoil of everyday life for more than one year …
witnessed tremendous distress, death, and turmoil of everyday life for more than one year …
Myocarditis associated with Covid‐19 disease: a systematic review of published case reports and case series
Background Covid‐19 is an extremely contagious illness caused by the severe acute
respiratory syndrome (SARS‐CoV‐2) virus. The cardiac involvement in such a public health …
respiratory syndrome (SARS‐CoV‐2) virus. The cardiac involvement in such a public health …
[HTML][HTML] Vaccine development throughout history
The emergence of the coronavirus disease 2019 (COVID-19) pandemic has made us
appreciate how important it is to quickly develop treatments and save lives. The race to …
appreciate how important it is to quickly develop treatments and save lives. The race to …
Prevalence and clinical outcomes of pleural effusion in COVID‐19 patients: A systematic review and meta‐analysis
SS Rathore, N Hussain, AH Manju… - Journal of Medical …, 2022 - Wiley Online Library
Observational studies indicate that pleural effusion has an association with risk and the
clinical prognosis of COVID‐19 disease; however, the available literature on this area is …
clinical prognosis of COVID‐19 disease; however, the available literature on this area is …
Convalescent plasma and all-cause mortality of COVID-19 patients: systematic review and meta-analysis
N Mihalek, D Radovanović, O Barak, P Čolović… - Scientific Reports, 2023 - nature.com
Insight into the clinical potential of convalescent plasma in patients with coronavirus disease
(COVID-19) is important given the severe clinical courses in unvaccinated and seronegative …
(COVID-19) is important given the severe clinical courses in unvaccinated and seronegative …
Safety and efficacy of convalescent plasma in COVID-19: an overview of systematic reviews
Convalescent plasma (CP) from patients recovered from COVID-19 is one of the most
studied anti-viral therapies against SARS-COV-2 infection. The aim of this study is to …
studied anti-viral therapies against SARS-COV-2 infection. The aim of this study is to …
Convalescent plasma therapy against the emerging SARS-CoV-2 variants: delineation of the potentialities and risks
M Dhawan, M Parmar, S Angural… - International Journal of …, 2022 - journals.lww.com
Abstract Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2) has resulted in a catastrophic pandemic and …
syndrome coronavirus-2 (SARS-CoV-2) has resulted in a catastrophic pandemic and …
SARS-coV-2: an updated review highlighting its evolution and treatments
X Zhang, H Yuan, Z Yang, X Hu, YS Mahmmod, X Zhu… - Vaccines, 2022 - mdpi.com
Since the SARS-CoV-2 outbreak, pharmaceutical companies and researchers worldwide
have worked hard to develop vaccines and drugs to end the SARS-CoV-2 pandemic. The …
have worked hard to develop vaccines and drugs to end the SARS-CoV-2 pandemic. The …